Microba Life Sciences (ASX:MAP) Net Margin % : -350.99% (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Microba Life Sciences Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Microba Life Sciences's Net Income for the six months ended in Dec. 2023 was A$-11.49 Mil. Microba Life Sciences's Revenue for the six months ended in Dec. 2023 was A$3.27 Mil. Therefore, Microba Life Sciences's net margin for the quarter that ended in Dec. 2023 was -350.99%.

The historical rank and industry rank for Microba Life Sciences's Net Margin % or its related term are showing as below:

ASX:MAP' s Net Margin % Range Over the Past 10 Years
Min: -282.62 Med: -239.29 Max: -233.95
Current: -282.62

ASX:MAP's Net Margin % is ranked worse than
84.62% of 221 companies
in the Medical Diagnostics & Research industry
Industry Median: -12.7 vs ASX:MAP: -282.62

Microba Life Sciences Net Margin % Historical Data

The historical data trend for Microba Life Sciences's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Microba Life Sciences Net Margin % Chart

Microba Life Sciences Annual Data

Trend

Jun22

Jun23

Net Margin %

-244.62

-233.95

Microba Life Sciences Semi-Annual Data
	Dec21	Jun22	Dec22	Jun23	Dec23
Net Margin %	-	-	-264.02	-214.16	-350.99

Competitive Comparison of Microba Life Sciences's Net Margin %

For the Diagnostics & Research subindustry, Microba Life Sciences's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Microba Life Sciences's Net Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Microba Life Sciences's Net Margin % distribution charts can be found below:

* The bar in red indicates where Microba Life Sciences's Net Margin % falls into.

Microba Life Sciences Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Microba Life Sciences's Net Margin for the fiscal year that ended in Jun. 2023 is calculated as

Net Margin	=	Net Income (A: Jun. 2023 )	/	Revenue (A: Jun. 2023 )
	=	-12.68	/	5.42
	=	-233.95 %

Microba Life Sciences's Net Margin for the quarter that ended in Dec. 2023 is calculated as

Net Margin	=	Net Income (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-11.488	/	3.273
	=	-350.99 %

Microba Life Sciences (ASX:MAP) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Microba Life Sciences Net Margin % Related Terms

Thank you for viewing the detailed overview of Microba Life Sciences's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Microba Life Sciences (ASX:MAP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Microba Life Sciences Ltd (ASX:MAP) » Definitions » Net Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

324 Queen Street, Level 10, Brisbane, QLD, AUS, 4000

Website

https://www.microba.com

Microba Life Sciences Ltd is a commercial-stage company with technology for measuring the human gut microbiome which includes delivering gut microbiome testing services globally to consumers, clinicians, and researchers. The company's segment includes Testing Services, and Research and Development.

Microba Life Sciences (ASX:MAP) Headlines

No Headlines